Eagle Bay Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-115
Closed -$28.9K 203
2025
Q4
$28.9K Buy
+115
New +$30.5K 0.02% 211
2025
Q1
Sell
-150
Closed -$34.4K 593
2024
Q4
$34.4K Hold
150
0.02% 388
2024
Q3
$33.5K Hold
150
0.01% 518
2024
Q2
$30.5K Hold
150
0.02% 394
2024
Q1
$32.8K Hold
150
0.02% 357
2023
Q4
$34.1K Hold
150
0.02% 342
2023
Q3
$30.2K Sell
150
-25
-14% -$5.27K 0.01% 479
2023
Q2
$36.2K Sell
175
-4
-2% -$776 0.02% 427
2023
Q1
$35.3K Hold
179
0.02% 447
2022
Q4
$36.3K Buy
179
+37
+26% +$7.23K 0.02% 442
2022
Q3
$25K Hold
142
0.02% 476
2022
Q2
$28.6K Buy
+142
New +$30.3K 0.02% 487
2022
Q1
Sell
-132
Closed -$36K 654
2021
Q4
$36K Sell
132
-131
-50% -$32.4K 0.02% 456
2021
Q3
$64K Buy
263
+135
+105% +$34K 0.04% 339
2021
Q2
$31K Buy
+128
New +$29.2K 0.02% 449

Other funds holding LH

Eagle Bay Advisors's LH Position: Q1 2026 in Review

Eagle Bay Advisors sold out of Labcorp (LH) in Q1 2026, closing a stake of 115 shares — an estimated $28.9K sold.

Eagle Bay Advisors first reported a position in LH in Q2 2021 and held it in 15 quarters. The position peaked at $64K in Q3 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Eagle Bay Advisors reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • Eagle Bay Advisors sold 115 Labcorp shares in Q1 2026, an estimated $28.9K.
  • Eagle Bay Advisors first reported a position in Labcorp in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Labcorp position peaked at $64K in Q3 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.